Morningside Venture (I) Investments Ltd 13D/13G Filings for

Morningside Venture (I) Investments Ltd 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-09-23
5:20 pm
Unchanged
2022-09-2313DStealth BioTherapeutics Corp
MITO
Morningside Venture (I) Investments Ltd741,652,468
66.900%
0
(Unchanged)
Filing
2022-08-01
4:46 pm
Unchanged
2022-07-3113DStealth BioTherapeutics Corp
MITO
Morningside Venture (I) Investments Ltd741,652,468
66.900%
0
(Unchanged)
Filing
2022-06-27
4:49 pm
Purchase
2022-06-2413DStealth BioTherapeutics Corp
MITO
Morningside Venture (I) Investments Ltd741,652,468
66.900%
160,269,276increase
(+27.57%)
Filing
2021-12-10
4:21 pm
Purchase
2021-12-0113DStealth BioTherapeutics Corp
MITO
Morningside Venture (I) Investments Ltd581,383,192
68.100%
115,669,331increase
(+24.84%)
Filing
2021-02-17
4:00 pm
Unchanged
2020-12-3113DStealth BioTherapeutics Corp
MITO
Morningside Venture (I) Investments Ltd465,713,861
70.000%
0
(Unchanged)
Filing
2020-11-09
4:16 pm
Purchase
2020-10-3013DStealth BioTherapeutics Corp
MITO
Morningside Venture (I) Investments Ltd465,713,861
72.300%
46,153,846increase
(+11.00%)
Filing
2020-04-16
3:27 pm
Purchase
2020-04-1013DStealth BioTherapeutics Corp
MITO
Morningside Venture (I) Investments Ltd419,560,015
71.100%
152,858,460increase
(+57.31%)
Filing